127 related articles for article (PubMed ID: 37877395)
1. [Rac1 promotes the formation of heterotypic cell-in-cell structure].
Hu T; Feng P; Li H; Zhou L; Niu Z; Huang Y; Wang X; Wang C; Liu H; Wu C
Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4123-4134. PubMed ID: 37877395
[TBL] [Abstract][Full Text] [Related]
2. Rac1, A Potential Target for Tumor Therapy.
Liang J; Oyang L; Rao S; Han Y; Luo X; Yi P; Lin J; Xia L; Hu J; Tan S; Tang L; Pan Q; Tang Y; Zhou Y; Liao Q
Front Oncol; 2021; 11():674426. PubMed ID: 34079763
[TBL] [Abstract][Full Text] [Related]
3. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
4. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
5. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase.
Hudson LG; Gillette JM; Kang H; Rivera MR; Wandinger-Ness A
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30261690
[TBL] [Abstract][Full Text] [Related]
7. Rac1 inhibition protects the kidney against kidney ischemia/reperfusion through the inhibition of macrophage migration.
Park YR; Kong MJ; Noh MR; Park KM
Korean J Physiol Pharmacol; 2023 May; 27(3):257-265. PubMed ID: 37078299
[TBL] [Abstract][Full Text] [Related]
8. Ras-Related C3 Botulinum Toxin Substrate 1 Combining With the Mixed Lineage Kinase 3- Mitogen-Activated Protein Kinase 7- c-Jun N-Terminal Kinase Signaling Module Accelerates Diabetic Nephropathy.
Ying C; Dai J; Fan G; Zhou Z; Gan T; Zhang Y; Song Y; Zhou X
Front Physiol; 2021; 12():679166. PubMed ID: 34194338
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor receptor-α and Ras-related C3 botulinum toxin substrate-1 regulate mechano-responsiveness of lung fibroblasts.
McGowan SE; McCoy DM
Am J Physiol Lung Cell Mol Physiol; 2017 Dec; 313(6):L1174-L1187. PubMed ID: 28775097
[TBL] [Abstract][Full Text] [Related]
10. A novel interaction between the SH2 domain of signaling adaptor protein Nck-1 and the upstream regulator of the Rho family GTPase Rac1 engulfment and cell motility 1 (ELMO1) promotes Rac1 activation and cell motility.
Zhang G; Chen X; Qiu F; Zhu F; Lei W; Nie J
J Biol Chem; 2014 Aug; 289(33):23112-23122. PubMed ID: 24928514
[TBL] [Abstract][Full Text] [Related]
11. Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors.
De P; Rozeboom BJ; Aske JC; Dey N
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545340
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclic hydrodynamic pressure-induced proliferation of human bladder smooth muscle through Ras-related C3 botulinum toxin substrate 1, mitogen-activated protein kinase kinase 1/2 and extracellular regulated protein kinases 1/2.
Wu T; Chen L; Wei T; Wang Y; Xu F; Wang K
Int J Urol; 2012 Sep; 19(9):867-74. PubMed ID: 22574733
[TBL] [Abstract][Full Text] [Related]
13. Rac1 as a therapeutic anticancer target: Promises and limitations.
Bailly C; Beignet J; Loirand G; Sauzeau V
Biochem Pharmacol; 2022 Sep; 203():115180. PubMed ID: 35853497
[TBL] [Abstract][Full Text] [Related]
14. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
[TBL] [Abstract][Full Text] [Related]
15. ARF6-Rac1 signaling-mediated neurite outgrowth is potentiated by the neuronal adaptor FE65 through orchestrating ARF6 and ELMO1.
Chan WWR; Li W; Chang RCC; Lau KF
FASEB J; 2020 Dec; 34(12):16397-16413. PubMed ID: 33047393
[TBL] [Abstract][Full Text] [Related]
16. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.
Martínez-López A; García-Casas A; Infante G; González-Fernández M; Salvador N; Lorente M; Mendiburu-Eliçabe M; Gonzalez-Moreno S; Villarejo-Campos P; Velasco G; Malliri A; Castillo-Lluva S
Mol Oncol; 2024 Mar; 18(3):620-640. PubMed ID: 38098337
[TBL] [Abstract][Full Text] [Related]
17. Identification of potent and novel inhibitors against RAC1: a Rho family GTPase.
Madhukar G; Subbarao N
In Silico Pharmacol; 2022; 10(1):13. PubMed ID: 35928028
[TBL] [Abstract][Full Text] [Related]
18. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Toxin A Upregulates Rac1, Cdc42, and RhoA Gene Expression in a Dose-Dependent Manner: In Vivo and in Vitro Study.
Park TH; Park JH; Chang CH; Rah DK
J Craniofac Surg; 2016 Mar; 27(2):516-20. PubMed ID: 26963302
[TBL] [Abstract][Full Text] [Related]
20. In silico repurposing the Rac1 inhibitor NSC23766 for treating PTTG1-high expressing clear cell renal carcinoma.
Hsieh YY; Liu TP; Yang PM
Pathol Res Pract; 2019 Jun; 215(6):152373. PubMed ID: 30871916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
